BUSINESS

• Celgene Poised to Boost Japan Organization as New Launch Nears
  September 28, 2016

• Psoriasis Drug Lumicef to Hit Shelves on Sept. 30: Kyowa Kirin
  September 28, 2016

• Sawai Files Myrbetriq Generic in US, Its 2nd Product after Livalo Copy
  September 28, 2016

• Eisai Seeks Label Expansion for Fycompa to Include Monotherapy
  September 28, 2016

• Novel MR Antagonist Enters Japan PIII for Hypertension: Daiichi Sankyo
  September 28, 2016

• Otsuka-Lundbeck’s Alzheimer’s Med Idalopirdine Stumbles in PIII
  September 27, 2016

• Rexulti OK’ed for Schizophrenia Maintenance Therapy in US
  September 27, 2016

• Daiichi Sankyo Seeks RA Indication for Pralia
  September 26, 2016

• Takeda, France’s Affilogic Join Hands on CNS Drugs
  September 23, 2016

• Takeda Ties Up with India’s Zydus Cadila for Chikungunya Vaccine
  September 23, 2016

• Maruho Gets Japan Rights to Dermira’s Hyperhidrosis Treatment
  September 23, 2016

• Sumitomo Dainippon’s ADHD Drug Meets Primary Endpoint in US PII/III Study in Children
  September 23, 2016

• Astellas-Vical’s CMV Vaccine Disappoints in PII for Kidney Transplant Patients
  September 21, 2016

• In a Turnaround, EU Panel Backs Takeda’s Ninlaro for Conditional Approval
  September 21, 2016

• Entyvio Shows Favorable Benefits in Both TNF-Naïve, TNF-Failed UC Patients
  September 21, 2016

• Meiji Seika Pharma to Establish Medical Science Promotion Office in October
  September 21, 2016

• Nichi-Iko to Set up Biosimilar Dept. in October to Push Remicade Follow-On
  September 21, 2016

• Eisai Looks to Achieve CAGR of 55% for Fycompa with Add’l Indications
  September 20, 2016

• Ono, NCC Join Hands for Discovery of Anticancer Agents, Biomarker Research
  September 20, 2016

• Osaka Univ. Spinoff, Sumitomo Dainippon Ink Joint Research Pact on Antibody-Inducing Peptides
  September 20, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 467
• 468
• 469
• 470
• 471
• 472
• 473
• 474
• 475
• …
• Next ›
• 最終 »